Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer.

PURPOSE

To explore the effects of pelareorep on autophagy in multiple models of colorectal cancer, including patient-derived peripheral blood mononuclear cells (PBMCs).

EXPERIMENTAL DESIGN

HCT116 [KRAS mutant (mut)] and Hke3 [ wild-type (WT)] cells were treated with pelareorep (multiplicity of infection, 5) and harvested at 6 and 9 hours. LC3 A/B expression was determined by immunofluorescence and flow cytometry; five autophagic proteins were analyzed by Western blotting. The expression of 88 autophagy genes was determined by qRT-PCR. Syngeneic mouse models, CT26/Balb-C ( mut) and MC38/C57B6 ( WT), were developed and treated with pelareorep (10 × 10 plaque-forming unit/day) intraperitoneally. Protein and RNA were extracted from harvested tumor tissues. PBMCs from five experimental and three control patients were sampled at 0 (pre) and 48 hours, and on days 8 and 15. The gene expression normalized to "pre" was determined using 2 method.

RESULTS

Pelareorep induced significant upregulation of LC3 A/B in HCT116 as compared with Hke3 cells by immunofluorescence (3.24 × and 8.67 ×), flow cytometry (2.37 × and 2.58 ×), and autophagosome formation (2.02 × and 1.57 ×), at 6 and 9 hours, respectively; all < 0.05. Western blot analysis showed an increase in LC3 A/B (2.38 × and 6.82 ×) and Beclin1 (1.17 × and 1.24 ×) at 6 and 9 hours, ATG5 (2.4 ×) and P-62 (1.52 ×) at 6 hours, and VPS-34 (1.39 ×) at 9 hours (all < 0.05). Induction of 13 transcripts in cell lines (>4 ×; 6 and 9 hours; < 0.05), 12 transcripts in CT26 (qRT-PCR), and 14 transcripts in human PBMCs ( < 0.05) was observed. , and expression was upregulated in all three model systems.

CONCLUSIONS

Pelareorep hijacks host autophagic machinery in -mut conditions to augment its propagation and preferential oncolysis of the cancer cells.